跳至主要内容
临床试验/CTRI/2018/03/012451
CTRI/2018/03/012451已完成1 期

Patch Test (Skin Irritation)

Dabur India Limited0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Availability of subject for the entire study period and willingness to adhere to protocol requirements as evidenced by the written
  • informed consent.
  • 2. Normal findings in the physical and clinical examinations.
  • 3. Clinical Laboratory values within 10% above or below the laboratoryâ??s stated normal range, unless the investigators along with physicians decide that they are not clinically significant and record this fact on the case report form.
  • 4. A Non-Smoker.
  • 5. Asian males of Indian origin.

排除标准

  • 1. History of hypersensitivity to the study formulations or related
  • 2. Significant history or presence of psychiatric, gastro intestinal, liver
  • or kidney disorder/impairments, or any other conditions known to
  • interfere with the absorption, distribution, metabolism or excretion of
  • common medications.
  • 3. Significant history of asthma, chronic bronchitis or other
  • bronchospastic condition.
  • 4. Significant history or presence of glaucoma, cardiovascular or
  • hematological disease.
  • 5. Any clinically significant illness during the 4 weeks prior to day one
  • of this study.
  • 6. Maintenance therapy with any drug, or history of drug
  • dependency, alcohol abuse, or serious neurological or psychological
  • 7. Participation in a clinical trial with an investigation drug within
  • 90days preceding day 1 of the current study.
  • 8. Use of enzyme-modifying drugs within 30 days prior to day 1 of
  • this study.
  • 9. Use of any systemic medication (including OTC preparations)
  • within 14 days proceeding day 1 of this study.
  • 10. HIV and Hepatitis and Australian Antigen positive volunteers.

研究者

相似试验